Mark C. Schiller - Jul 2, 2024 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role: Chief Legal Officer
Signature: /s/ Marc Belsky, Attorney-in-Fact
Stock symbol: KZR
Transactions as of: Jul 2, 2024
Transactions value $: -$3,879
Form type: 4
Date filed: 7/26/2024, 05:41 PM
Previous filing: Jan 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KZR	Common Stock	Sale	-$3.88K	-6.69K	-16.85%	$0.58	33K	Jul 2, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Content

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.